NEW YORK (GenomeWeb News) – The US Food and Drug Administration this week gave 510(k) clearance to Beckman Coulter's Access AccuTnl+3 troponin l assay for use on the company's Access 2 immunoassay system.
The Molecular Diagnostics Research Group at the National University of Ireland, Galway, has ramped up its commercial activity in recent months in an attempt to market the group's innovations — particularly novel nucleic acid targets for infectious diseases — as well as its assay design and
US President Barack Obama has named Institute for Systems Biology president Leroy Hood and Frederick Hawthorne, director of the Institute of Nano and Molecular Medicine at the University of Missouri at Columbia,
Danish diagnostic technology developer Atonomics has published a paper describing its proprietary nested PCR technology and has demonstrated its ability to simultaneously detect multiple yeast and bacterial nucleic acid targets more quickly, and with a lower limit of detection, t
In purchasing Beckman Coulter Genomics' Morrisville, NC, facility, research services firm ILS has garnered a number of capabilities that will enable it to establish a presence in pharmacogenomics and personalized medicine.